Best Autologous Chondrocyte Implantation (ACI) Hospitals in India

With advanced orthopaedic and cartilage-care infrastructure, BLK-Max Super Speciality Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1959, the JCI, NABH hospital is located in Delhi, India, and has 650 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.

With advanced orthopaedic and cartilage-care infrastructure, Medanta - The Medicity offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2009, the JCI, NABH hospital is located in Gurgaon, India, and has 1250 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.

Max Hospital, Gurgaon offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2007, the ISO, NABH, NABL hospital is located in Gurgaon, India, with 104 beds and provides specialised orthopaedic care for local and international patients.

ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.

Fortis Escorts Heart Institute, Okhla provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1988, the NABL hospital is based in Delhi, India, with 310 beds and services for domestic and international patients.

During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.

At Indraprastha Apollo Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1996, the JCI hospital is located in Delhi, India, and has 710 beds.

ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.

Apollo Hospitals provides Autologous Chondrocyte Implantation using contemporary cell-based cartilage repair techniques and evidence-based orthopaedic care. Founded in 1988, the JCI hospital is based in Hyderabad, India, with 550 beds and services for domestic and international patients.

During ACI, a small sample of healthy cartilage is collected, and the chondrocytes are expanded under controlled laboratory conditions. The cultured cells are subsequently placed into the cartilage defect to support tissue repair. Before treatment, specialists assess cartilage damage, joint alignment, stability, imaging findings, and the patient's overall health.

Star Hospitals offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2008, the NABH, NABL hospital is situated in Hyderabad, India, with 435 beds, serving local and international patients.

ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.

Global Health City offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1999, the NABH, NABL hospital is situated in Chennai, India, with 200 beds, serving local and international patients.

ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.

nanavati Super Speciality Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 1950, the NABH hospital is located in Mumbai, India, with 350 beds and provides specialised orthopaedic care for local and international patients.

ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.

At Max Super Speciality Hospital, Patparganj, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2005, the NABH, NABL, AACI hospital is located in Delhi, India, and has 400 beds.

ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.

Tx Hospitals Banjara Hills offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2020, the JCI, NABH hospital is located in Hyderabad, India, with 100 beds and provides specialised orthopaedic care for local and international patients.

ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.

With advanced orthopaedic and cartilage-care infrastructure, Fortis Flt. Lt. Rajan Dhall Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2006, the NABH hospital is located in Delhi, India, and has 162 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.

Fortis Hospital, Mulund offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2002, the JCI, NABH hospital is located in Mumbai, India, with 315 beds and provides specialised orthopaedic care for local and international patients.

ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.

With advanced orthopaedic and cartilage-care infrastructure, Manipal Hospital, Hebbal offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 1991, the NABL, NABH hospital is located in Bangalore, India, and has 280 beds.

ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.

Max Super Speciality Hospital, Saket offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2006, the JCI, NABH hospital is situated in Delhi, India, with 539 beds, serving local and international patients.

ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.